To identify the effects of combination therapies on osteosarcoma in vitro, two types of osteosarcoma cell lines were studied, including P53(+) U2OS cells and P53(−) SAOS2 cells, to mimic the different osteosarcoma types [54]. This evidence concerns the gene TP53 and osteosarcoma.